1. Home
  2. BBD vs STE Comparison

BBD vs STE Comparison

Compare BBD & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Bradesco Sa

BBD

Banco Bradesco Sa

HOLD

Current Price

$3.49

Market Cap

30.6B

Sector

Finance

ML Signal

HOLD

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

HOLD

Current Price

$259.41

Market Cap

24.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBD
STE
Founded
1943
1985
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.6B
24.5B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
BBD
STE
Price
$3.49
$259.41
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$2.55
$268.25
AVG Volume (30 Days)
27.9M
579.0K
Earning Date
02-05-2026
02-04-2026
Dividend Yield
4.84%
0.97%
EPS Growth
47.11
59.39
EPS
0.38
6.97
Revenue
$16,507,289,161.00
$5,702,415,000.00
Revenue This Year
$78.18
$9.61
Revenue Next Year
$7.75
$6.23
P/E Ratio
$8.69
$37.25
Revenue Growth
16.68
7.08
52 Week Low
$1.85
$203.35
52 Week High
$3.77
$268.60

Technical Indicators

Market Signals
Indicator
BBD
STE
Relative Strength Index (RSI) 55.07 55.63
Support Level $3.35 $246.65
Resistance Level $3.60 $257.24
Average True Range (ATR) 0.06 4.46
MACD 0.02 0.38
Stochastic Oscillator 70.00 78.27

Price Performance

Historical Comparison
BBD
STE

About BBD Banco Bradesco Sa

Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Share on Social Networks: